-
A Crispr therapy is designed to attack tumors.
Scientists at University of Pennsylvania in the US have discovered a way to personalise cancer therapy by editing and transporting gene expression to cancerous cells. They infused the edited cells back into volunteers who had previously been treated with several rounds of chemotherapy. The edited cells travelled to the tumors and killed them.
-
The success of the CRISPR cancer trial paves way for personalized treatments.
University of Pennsylvania researchers have developed a new approach to personalise personalised T-cell therapies for solid tumors. They isolated T cells from blood of 16 patients with solid tumors, including colon, breast, or lung cancer. The team chose up to three receptors for each patient and added the genes for these receptors to the person’s…